U.S. House · 117th Congress · H.R. 4991
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2021
To require persons who undertake federally funded research and development of a biomedical product or service to enter into reasonable pricing agreements with the Secretary of Health and Human Services, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Peter A. DeFazioD-OR-4
- Introduced
- August 10, 2021, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (11)
11 Democrats. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Steve CohenD-TN-9
- Lloyd DoggettD-TX-35
- Raúl M. GrijalvaD-AZ-3
- Marcy KapturD-OH-9
- Ro KhannaD-CA-17
- Mark PocanD-WI-2
- Janice D. SchakowskyD-IL-9
Signed on later
- Chellie PingreeD-ME-1August 27, 2021
- Jesús G. "Chuy" GarcíaD-IL-4September 7, 2021
- Rosa L. DeLauroD-CT-3September 20, 2021
- Melanie A. StansburyD-NM-1July 27, 2022